• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2024 Back

31 May - 03 June 2024 Valencia, Spain

Giorgio W Canonica

Italy

Giorgio W Canonica

Distinguished Professor & Senior Consultant Personalized Medicine Asthma & Allergy at Humanitas University & Research Hospital Milano Italy

Topics of Research:

Asthma Biologics, Allergen ImmunoTherapy Personalized Medicine

H index 143; Citations >100.000

https://orcid.org/0000-0001-8467-2557

Sessions

Friday 31 May
12:00 - 13:00
SAT1-3 Sanofi Regeneron - On-Treatment Clinical Remission in Upper and Lower Airways: Going Beyond Symptom Control Sponsored Sessions Alicante , Channel Alicante
12:00 - 12:05 Welcome
12:05 - 12:10 Moving Beyond Control to On-Treatment Clinical Remission
12:35 - 12:55 Panel Discussion
12:55 - 13:00 Q&A
13:45 - 14:45
SAT1-4 Stallergenes Greer - "Allergen Harmony": New data for a tailored and sustained food and respiratory immunotherapy effect Sponsored Sessions Almeria , Channel Almeria
14:35 - 14:45 Panel Discussions and Questions
Saturday 1 Jun
12:00 - 12:07 Real-world change in asthma symptom control and oral corticosteroid use in patients with severe asthma treated with mepolizumab stratified by atopic status: Post hoc analysis of REALITI-A at 2 years
15:40 - 16:10 Empowering Patients: Innovations in Allergic Rhinoconjuntivitis treatment
Monday 3 Jun
11:00 - 12:30
SY32 Innovation in experimental medicine: State-of-the-art Symposia Barcelona , Channel Barcelona
13:27 - 13:34 Impact of mepolizumab on exacerbations and maintenance OCS use in patients with asthma and baseline blood eosinophil counts of ≥150–<300 cells/μL in the REALITI-A study: 2-year outcomes
×